HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lane Labs Must Discontinue SkinAnswer Cancer Claims Under Injunction

This article was originally published in The Rose Sheet

Executive Summary

The seven-year struggle between federal regulators and dietary supplement marketer Lane Labs-USA has formally concluded with a permanent injunction issued in Newark, N.J. federal court July 13

You may also be interested in...

Lane Labs

Dietary supplement firm has discontinued manufacturing skin cream SkinAnswer and two nutritional supplements, Benefin and MGN-3, the company announces, after a permanent injunction was issued July 13 barring the firm from selling the products unless approved by FDA. "We are very disappointed and will pursue an appeal," the company says in a statement. Lane Labs argues the products represent a breakthrough in the natural health industry, but court rules that the items, marketed as cancer therapies, are unapproved new drugs (1"The Rose Sheet" July 19, 2004, p. 7)...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts